【4517】ビオフェルミン製薬
〔上場廃止〕
ー(上場廃止)大衆薬中心。『ビオフェルミン』。親会社は大正製薬HLD。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022.03 | 2021/05/12 | 当初予 | 11,100 | - | - | - | 1,970 | - | - | - | 2,040 | - | - | - | 1,460 | - | - | - |
2021.03 | 2021/05/12 | 実 | 10,811 | ↓ | -1.0% | -1.0% | 2,058 | ↓ | -5.6% | -5.6% | 2,120 | ↓ | -5.8% | -5.8% | 1,548 | ↓ | -0.8% | -0.8% |
2021.03 | 2021/01/21 | Q3予 | 10,920 | → | 0.0% | 0.0% | 2,180 | → | 0.0% | 0.0% | 2,250 | → | 0.0% | 0.0% | 1,560 | → | 0.0% | 0.0% |
2021.03 | 2020/10/22 | Q2予 | 10,920 | → | 0.0% | 0.0% | 2,180 | → | 0.0% | 0.0% | 2,250 | → | 0.0% | 0.0% | 1,560 | → | 0.0% | 0.0% |
2021.03 | 2020/07/22 | Q1予 | 10,920 | → | 0.0% | 0.0% | 2,180 | → | 0.0% | 0.0% | 2,250 | → | 0.0% | 0.0% | 1,560 | → | 0.0% | 0.0% |
2021.03 | 2020/05/12 | 当初予 | 10,920 | - | - | - | 2,180 | - | - | - | 2,250 | - | - | - | 1,560 | - | - | - |
2020.03 | 2020/05/12 | 実 | 11,924 | ↓ | -0.2% | +1.9% | 3,068 | ↑ | +9.6% | +23.7% | 3,139 | ↑ | +10.1% | +25.1% | 2,240 | ↑ | +9.3% | +27.3% |
2020.03 | 2020/01/29 | Q3予 | 11,950 | ↑ | +2.1% | +2.1% | 2,800 | ↑ | +12.9% | +12.9% | 2,850 | ↑ | +13.5% | +13.5% | 2,050 | ↑ | +16.5% | +16.5% |
2020.03 | 2019/10/29 | Q2予 | 11,700 | → | 0.0% | 0.0% | 2,480 | → | 0.0% | 0.0% | 2,510 | → | 0.0% | 0.0% | 1,760 | → | 0.0% | 0.0% |
2020.03 | 2019/07/23 | Q1予 | 11,700 | → | 0.0% | 0.0% | 2,480 | → | 0.0% | 0.0% | 2,510 | → | 0.0% | 0.0% | 1,760 | → | 0.0% | 0.0% |
2020.03 | 2019/05/09 | 当初予 | 11,700 | - | - | - | 2,480 | - | - | - | 2,510 | - | - | - | 1,760 | - | - | - |
2019.03 | 2019/05/09 | 実 | 11,542 | ↑ | +4.7% | +4.7% | 3,186 | ↓ | -2.6% | -2.6% | 3,273 | ↓ | -0.2% | -0.2% | 2,305 | ↑ | +0.2% | +0.2% |
2019.03 | 2019/01/29 | Q3予 | 11,025 | → | 0.0% | 0.0% | 3,270 | → | 0.0% | 0.0% | 3,280 | → | 0.0% | 0.0% | 2,300 | → | 0.0% | 0.0% |
2019.03 | 2018/10/24 | Q2予 | 11,025 | → | 0.0% | 0.0% | 3,270 | → | 0.0% | 0.0% | 3,280 | → | 0.0% | 0.0% | 2,300 | → | 0.0% | 0.0% |
2019.03 | 2018/07/26 | Q1予 | 11,025 | → | 0.0% | 0.0% | 3,270 | - | - | - | 3,280 | → | 0.0% | 0.0% | 2,300 | → | 0.0% | 0.0% |
2019.03 | 2018/05/10 | 当初予 | 11,025 | - | - | - | - | - | - | - | 3,280 | - | - | - | 2,300 | - | - | - |
2018.03 | 2018/05/10 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
2018.03 | 2018/01/30 | Q3予 | 10,620 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% | 2,730 | → | 0.0% | 0.0% | 1,900 | → | 0.0% | 0.0% |
2018.03 | 2017/10/27 | Q2予 | 10,620 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% | 2,730 | → | 0.0% | 0.0% | 1,900 | → | 0.0% | 0.0% |
2018.03 | 2017/07/28 | Q1予 | 10,620 | → | 0.0% | 0.0% | 2,700 | → | 0.0% | 0.0% | 2,730 | → | 0.0% | 0.0% | 1,900 | → | 0.0% | 0.0% |
2018.03 | 2017/05/12 | 当初予 | 10,620 | - | - | - | 2,700 | - | - | - | 2,730 | - | - | - | 1,900 | - | - | - |
2017.03 | 2017/05/12 | 実 | 10,618 | ↑ | +3.1% | +3.1% | 2,698 | ↑ | +14.8% | +14.8% | 2,709 | ↑ | +12.9% | +12.9% | 1,899 | ↑ | +11.7% | +11.7% |
2017.03 | 2017/01/31 | Q3予 | 10,300 | → | 0.0% | 0.0% | 2,350 | → | 0.0% | 0.0% | 2,400 | → | 0.0% | 0.0% | 1,700 | → | 0.0% | 0.0% |
2017.03 | 2016/10/28 | Q2予 | 10,300 | → | 0.0% | 0.0% | 2,350 | → | 0.0% | 0.0% | 2,400 | → | 0.0% | 0.0% | 1,700 | → | 0.0% | 0.0% |
2017.03 | 2016/07/29 | Q1予 | 10,300 | → | 0.0% | 0.0% | 2,350 | → | 0.0% | 0.0% | 2,400 | → | 0.0% | 0.0% | 1,700 | → | 0.0% | 0.0% |
2017.03 | 2016/05/13 | 当初予 | 10,300 | - | - | - | 2,350 | - | - | - | 2,400 | - | - | - | 1,700 | - | - | - |
2016.03 | 2016/05/13 | 実 | 9,666 | ↑ | +0.7% | -7.9% | 2,278 | ↑ | +3.5% | -21.4% | 2,326 | ↑ | +1.1% | -22.5% | 1,589 | ↑ | +1.9% | -20.6% |
2016.03 | 2016/02/03 | Q3予 | 9,600 | ↓ | -8.6% | -8.6% | 2,200 | ↓ | -24.1% | -24.1% | 2,300 | ↓ | -23.3% | -23.3% | 1,560 | ↓ | -22.0% | -22.0% |
2016.03 | 2015/10/28 | Q2予 | 10,500 | → | 0.0% | 0.0% | 2,900 | → | 0.0% | 0.0% | 3,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% |
2016.03 | 2015/07/27 | Q1予 | 10,500 | → | 0.0% | 0.0% | 2,900 | → | 0.0% | 0.0% | 3,000 | → | 0.0% | 0.0% | 2,000 | → | 0.0% | 0.0% |
2016.03 | 2015/05/11 | 当初予 | 10,500 | - | - | - | 2,900 | - | - | - | 3,000 | - | - | - | 2,000 | - | - | - |
2015.03 | 2015/05/11 | 実 | 10,845 | ↑ | +0.4% | +2.3% | 3,365 | ↑ | +10.3% | +14.1% | 3,468 | ↑ | +10.4% | +15.6% | 2,275 | ↑ | +13.7% | +16.7% |
2015.03 | 2015/01/28 | Q3予 | 10,800 | → | 0.0% | +1.9% | 3,050 | → | 0.0% | +3.4% | 3,140 | → | 0.0% | +4.7% | 2,000 | → | 0.0% | +2.6% |
2015.03 | 2014/10/29 | Q2予 | 10,800 | ↑ | +1.9% | +1.9% | 3,050 | ↑ | +3.4% | +3.4% | 3,140 | ↑ | +4.7% | +4.7% | 2,000 | ↑ | +2.6% | +2.6% |
2015.03 | 2014/07/25 | Q1予 | 10,600 | → | 0.0% | 0.0% | 2,950 | → | 0.0% | 0.0% | 3,000 | → | 0.0% | 0.0% | 1,950 | → | 0.0% | 0.0% |
2015.03 | 2014/05/09 | 当初予 | 10,600 | - | - | - | 2,950 | - | - | - | 3,000 | - | - | - | 1,950 | - | - | - |
2014.03 | 2014/05/09 | 実 | 10,532 | - | - | - | 3,211 | - | - | - | 3,296 | - | - | - | 2,162 | - | - | - |